J&J $40B Loss In Market Cap On Talc Report 'Seems Excessive,' Says Wells Fargo
December 16, 2018 at 15:22 PM EST
Wells Fargo analyst Lawrence Biegelsen believes Johnson & Johnson shares have been oversold based on today's Reuters article suggesting that the company knew about asbestos in its baby powder for decades but never told the FDA.
